edoc

Items where Author is "Hirschel, B."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 28.

2013

Cusini, A. and Vernazza, P. L. and Yerly, S. and Decosterd, L. A. and Ledergerber, B. and Fux, C. A. and Rohrbach, J. and Widmer, N. and Hirschel, B. and Gaudenz, R. and Cavassini, M. and Klimkait, T. and Zenger, F. and Gutmann, C. and Opravil, M. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid. JAIDS: journal of acquired immune deficiency syndromes, Vol. 62, H. 1. pp. 28-35.

Beerenwinkel, N. and Montazeri, H. and Schuhmacher, H. and Knupfer, P. and von Wyl, V. and Furrer, H. and Battegay, M. and Hirschel, B. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Yerly, S. and Boni, J. and Klimkait, T. and Cellerai, C. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients. PLoS Computational Biology, Vol. 9, H. 8 , e1003203.

2012

Stern, M. and Czaja, K. and Rauch, A. and Rickenbach, M. and Gunthard, H. F. and Battegay, M. and Fellay, J. and Hirschel, B. and Hess, C. and Swiss, H. I. V. Cohort Study Group. (2012) HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption. HIV medicine, Vol. 13, H. 10. pp. 589-595.

2011

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical infectious diseases, Vol. 52, H. 4. pp. 532-539.

El Amari, E. Boffi and Combescure, C. and Yerly, S. and Calmy, A. and Kaiser, L. and Hasse, B. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, Hh and Bernasconi, E. and Hirschel, B. and Swiss HIV Cohort Study, . (2011) Clinical relevance of cytomegalovirus viraemia(*,†). HIV medicine, Vol. 12, H. 7. pp. 394-402.

Young, J. and Scherrer, A. U. and Günthard, H. F. and Opravil, M. and Yerly, S. and Böni, J. and Rickenbach, M. and Fux, C. A. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Battegay, M. and Bucher, H. C. and Swiss HIV Cohort Study, . (2011) Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients : the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 299-307.

Schüpbach, Jörg and Bisset, Leslie R. and Regenass, Stephan and Bürgisser, Philippe and Gorgievski, Meri and Steffen, Ingrid and Andreutti, Corinne and Martinetti, Gladys and Shah, Cyril and Yerly, Sabine and Klimkait, Thomas and Gebhardt, Martin and Schöni-Affolter, Franziska and Rickenbach, Martin and Swiss HIV Cohort Study, and Barth, J. and Battegay, M. and Bernascon, E. and Böni, J. and Bucher, H. C. and Bürgisser, P. and Burton-Jeangros, C. and Calmy, A. and Cavassini, M. and Dubs, R. and Egger, M. and Elzi, L. and Fehr, J. and Fischer, M. and Flepp, M. and Francioli, P. and Furrer, H. and Fux, C. A. and Gorgievski, M. and Günthard, H. and Hasse, B. and Hirsch, H. H. and Hirschel, B. and Hösli, I. and Kahlert, C. and Kaiser, L. and Keiser, O. and Kind, C. and Klimkait, T. and Kovari, H. and Ledergerber, B. and Martinetti, G. and Martinez de Tejada, B. and Müller, N. and Nadal, D. and Pantaleo, G. and Rauch, A. and Regenass, S. and Rickenbach, M. and Rudin, C. and Schmid, P. and Schultze, D. and Schöni-Affolter, F. and Schüpbach, J. and Speck, R. and Taffé, P. and Telenti, A. and Trkola, A. and Vernazza, P. and von Wyl, V. and Weber, R. and Yerly, S.. (2011) High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC infectious diseases, Vol. 11 , 254. p. 254.

Magenta, L. and Dell-Kuster, S. and Richter, W. O. and Young, J. and Hasse, B. and Flepp, M. and Hirschel, B. and Vernazza, P. and Evison, J. and Cavassini, M. and Decosterd, L. A. and Bucher, H. C. and Bernasconi, E. and Swiss HIV Cohort Study, . (2011) Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS research and human retroviruses, Vol. 27, H. 5. pp. 525-533.

Ledergerber, B. and Cavassini, M. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Furrer, H. and Rickenbach, M. and Weber, R. and Swiss HIV Cohort Study, . (2011) Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 279-288.

Scherrer, A. U. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Burgisser, P. and Garzoni, C. and Hirschel, B. and Cavassini, M. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2011) Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS, Vol. 57, H. 1. pp. 24-31.

2010

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2010) Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection. Antiviral therapy, Vol. 15 , A158-A158.

2009

Combescure, Christophe and Vallier, N. and Ledergerber, B. and Cavassini, M. and Furrer, H. and Rauch, A. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B.. (2009) How reliable is an undetectable viral load? HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 470-476.

2008

Battegay, M. and Hirschel, B.. (2008) 11th European AIDS Conference (EACS) - Conference Scene. Future HIV Therapy, Vol. 2, no. 1. pp. 21-24.

Wunder, D. M. and Fux, C. A. and Bersinger, N. A. and Mueller, N. J. and Hirschel, B. and Cavassini, M. and Elzi, L. and Schmid, P. and Bernasconi, E. and Mueller, B. and Furrer, H. and Swiss, HIV Cohort Study. (2008) Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy : a case-control study. HIV medicine, Vol. 9. pp. 427-432.

Keiser, O. and Gayet-Ageron, A. and Rudin, C. and Brinkhof, M. W. and Gremlich, E. and Wunder, D. and Drack, G. and Hirschel, B. and de Tejada, B. M. and Swiss, HIV Cohort Study and Swiss, Mother and Child, HIV Cohort Study. (2008) Antiretroviral treatment during pregnancy. AIDS, Vol. 22. pp. 2323-2330.

Khanna, N. and Opravil, M. and Furrer, H. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Weber, R. and Hirschel, B. and Battegay, M. and Kaufmann, G. R. and Swiss, HIV Cohort Study. (2008) CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis, Vol. 47. pp. 1093-1101.

Ananworanich, J. and Nuesch, R. and Côté, H. C. and Kerr, S. J. and Hill, A. and Jupimai, T. and Laopraynak, N. and Saenawat, S. and Ruxrungtham, K. and Hirschel, B.. (2008) Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine : a Staccato trial substudy. The Journal of antimicrobial chemotherapy, Vol. 61. pp. 1340-1343.

Wolbers, M. and Bucher, H. C. and Furrer, H. and Rickenbach, M. and Cavassini, M. and Weber, R. and Schmid, P. and Bernasconi, E. and Hirschel, B. and Battegay, M. and Swiss, HIV Cohort Study. (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine, Vol. 9. pp. 397-405.

Vo, T. T. and Ledergerber, B. and Keiser, O. and Hirschel, B. and Furrer, H. and Battegay, M. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Weber, R. and Swiss, HIV Cohort Study. (2008) Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of infectious diseases, Vol. 197, no. 12. pp. 1685-1694.

von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Battegay, M. and Bernasconi, E. and Cavassini, M. and Furrer, H. and Hirschel, B. and Vernazza, P. L. and Rickenbach, M. and Ledergerber, B. and Günthard, H. F. and Swiss, HIV Cohort Study. (2008) Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases, Vol. 46. pp. 1299-1309.

Rauch, A. and Nolan, D. and Furrer, H. and McKinnon, E. and John, M. and Mallal, S. and Gaudieri, S. and Günthard, H. F. and Schmid, P. and Battegay, M. and Hirschel, B. and Telenti, A. and James, I. and Swiss, HIV Cohort Study. (2008) HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. Clinical infectious diseases, Vol. 46. pp. 1921-1925.

Nüesch, R. and Ananworanich, J. and Srasuebkul, P. and Chetchotisakd, P. and Prasithsirikul, W. and Klinbuayam, W. and Mahanontharit, A. and Jupimai, T. and Ruxrungtham, K. and Hirschel, B.. (2008) Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. AIDS, Vol. 22. pp. 152-154.

Franceschi, S. and Maso, L. D. and Rickenbach, M. and Polesel, J. and Hirschel, B. and Cavassini, M. and Bordoni, A. and Elzi, L. and Ess, S. and Jundt, G. and Mueller, N. and Clifford, G. M.. (2008) Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British journal of cancer, Vol. 99, no. 5. pp. 800-804.

Nguyen, A. and Calmy, A. and Schiffer, V. and Bernasconi, E. and Battegay, M. and Opravil, M. and Evison, J. M. and Tarr, P. E. and Schmid, P. and Perneger, T. and Hirschel, B. and Swiss, HIV Cohort Study. (2008) Lipodystrophy and weight changes : data from the Swiss HIV Cohort Study, 2000-2006. HIV medicine, Vol. 9. pp. 142-150.

Ananworanich, J. and Gayet-Ageron, A. and Ruxrungtham, K. and Chetchotisakd, P. and Prasithsirikul, W. and Kiertiburanakul, S. and Munsakul, W. and Raksakulkarn, P. and Tansuphasawadikul, S. and LeBraz, M. and Jupimai, T. and Ubolyam, S. and Schutz, M. and Hirschel, B. and Staccato, Thailand Study Group. (2008) Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. Antiviral therapy, Vol. 13. pp. 375-380.

El Amari, E. B. and Toutous-Trellu, L. and Gayet-Ageron, A. and Baumann, M. and Cathomas, G. and Steffen, I. and Erb, P. and Mueller, N. J. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, H. H. and Bernasconi, E. and Hirschel, B. and Swiss, HIV Cohort Study. (2008) Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS, Vol. 22. pp. 1019-1028.

Glass, T. R. and De Geest, S. and Hirschel, B. and Battegay, M. and Furrer, H. and Covassini, M. and Vernazza, P. L. and Bernasconi, E. and Rickenboch, M. and Weber, R. and Bucher, H. C. and Swiss, HIV Cohort Study. (2008) Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, Vol. 13. pp. 77-85.

Fox, Z. and Phillips, A. and Cohen, C. and Neuhaus, J. and Baxter, J. and Emery, S. and Hirschel, B. and Hullsiek, K. H. and Stephan, C. and Lundgren, J. and Smart, Study Group. (2008) Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS, Vol. 22. pp. 2279-2289.

This list was generated on Fri Dec 4 03:47:20 2020 CET.